Bicara Therapeutics Appoints Ryan Cohlhepp As President & CEO Effective January 2027
BCAX•Company announces leadership transitions
Aug. 11 (Reuters) - Bicara Therapeutics Inc. BCAX.O:
- Bicara Therapeutics reports second quarter 2026 progress and announces strategic leadership transitions marking next era of execution and growth.
- Bicara Therapeutics appoints Ryan Cohlhepp as president & CEO effective January 2027.
- Bicara Therapeutics appoints Jenn Larson as CFO effective August 12, 2026.
Source text: ID:nGNXbM4VZ4
Further company coverage: BCAX.O
